NTRK1 fusion in glioblastoma multiforme

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Kim, Jinkuk ^a,b   Lee, Yeri ^a,c   Cho, Hee Jin ^a,c   Lee, Young Eun ^a,c   An, Jaeyeol ^a,c   Cho, Gye Hyun ^a   Ko, Young Hyeh ^a,d   Joo, Kyeung Min ^a,c,d   Nam, Do Hyun ^a,c,d  

^a Samsung Medical Center   (South Korea)

^b SAMSUNG Electronics   (South Korea)

^c Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^d Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BREVICAN; NERVE GROWTH FACTOR; BCAN PROTEIN, HUMAN; BCAN-NTRK1 FUSION PROTEIN, HUMAN; CELL ADHESION MOLECULE; NFASC PROTEIN, HUMAN; NFASC-NTRK1 FUSION PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN TYROSINE KINASE A;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BCAN GENE; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; EXON; FUSION GENE; GENE EXPRESSION; GENE FUNCTION; GENE FUSION; GENE STRUCTURE; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NFASC GENE; NONHUMAN; NTRK1 GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; RNA SEQUENCE; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; 3T3 CELL LINE; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BRAIN TUMOR; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; NUDE MOUSE; PATHOLOGY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN NEOPLASMS; BREVICAN; CARCINOGENESIS; CELL ADHESION MOLECULES; GLIOBLASTOMA; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; NERVE GROWTH FACTORS; NIH 3T3 CELLS; ONCOGENE PROTEINS, FUSION; RECEPTOR, TRKA;

EID: 84898657475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091940     Document Type: Article

References (30)

1. Bai RY, Staedtke V, Riggins GJ (2011) Molecular targeting of glioblastoma: Drug discovery and therapies. Trends Mol Med 17: 301-312.
2. Druker BJ (2009) Perspectives on the development of imatinib and the future of cancer research. Nat Med 15: 1149-1152.
3. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, et al. (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448: 561-566. (Pubitemid 47206930)
4. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648. (Pubitemid 41528150)
5. Ju YS, Lee WC, Shin JY, Lee S, Bleazard T, et al. (2012) A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res 22: 436-445.
6. Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, et al. (2012) Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 337: 1231-1235.
7. The Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
8. Sboner A, Habegger L, Pflueger D, Terry S, Chen DZ, et al. (2010) FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data. Genome Biol 11: R104.
9. Kalyana-Sundaram S, Shankar S, Deroo S, Iyer MK, Palanisamy N, et al. (2012) Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer. Neoplasia 14: 702-708.
10. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, et al. (2013) The somatic genomic landscape of glioblastoma. Cell 155: 462-477.
11. Frattini V, Trifonov V, Chan JM, Castano A, Lia M, et al. (2013) The integrated landscape of driver genomic alterations in glioblastoma. Nat Genet 45: 1141-1149.
12. Shah N, Lankerovich M, Lee H, Yoon JG, Schroeder B, et al. (2013) Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data. BMC Genomics 14: 818.
13. Gomez N, Cohen P (1991) Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 353: 170-173. (Pubitemid 21912483)
14. Tacconelli A, Farina AR, Cappabianca L, Desantis G, Tessitore A, et al. (2004) TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. Cancer Cell 6: 347-360. (Pubitemid 39361436)
15. Festuccia C, Muzi P, Gravina GL, Millimaggi D, Speca S, et al. (2007) Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro. Int J Oncol 30: 193-200.
16. Martin-Zanca D, Hughes SH, Barbacid M (1986) A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319: 743-748. (Pubitemid 16145029)
17. Greco A, Miranda C, Pierotti MA (2010) Rearrangements of NTRK1 gene in papillary thyroid carcinoma. Mol Cell Endocrinol 321: 44-49.
18. Vaishnavi A, Capelletti M, Le AT, Kako S, Butaney M, et al. (2013) Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer. Nat Med 19: 1469-1472.
19. Ango F, di Cristo G, Higashiyama H, Bennett V, Wu P, et al. (2004) Ankyrin-based subcellular gradient of neurofascin, an immunoglobulin family protein, directs GABAergic innervation at purkinje axon initial segment. Cell 119: 257-272. (Pubitemid 39360907)
20. Yamada H, Watanabe K, Shimonaka M, Yamaguchi Y (1994) Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J Biol Chem 269: 10119-10126. (Pubitemid 24196631)
21. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101: 6062-6067. (Pubitemid 38520528)
22. Kas K, Voz ML, Roijer E, Astrom AK, Meyen E, et al. (1997) Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nat Genet 15: 170-174. (Pubitemid 27061636)
23. Thress K, Macintyre T, Wang H, Whitston D, Liu ZY, et al. (2009) Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway. Mol Cancer Ther 8: 1818-1827.
24. Jung EJ, Kim CW (2010) Caveolin-1 inhibits TrkA-induced cell death by influencing on TrkA modification associated with tyrosine-490 phosphorylation. Biochem Biophys Res Commun 402: 736-741.
25. Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, et al. (2010) Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363: 1693-1703.
26. Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, et al. (2012) Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 487: 505-509.
27. Joo KM, Kim J, Jin J, Kim M, Seol HJ, et al. (2013) Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. Cell Rep 3: 260-273.
28. Arevalo JC, Conde B, Hempstead BL, Chao MV, Martin-Zanca D, et al. (2000) TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor. Mol Cell Biol 20: 5908-5916. (Pubitemid 30613040)
29. Wu TD, Nacu S (2010) Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics 26: 873-881.
30. Hoshida Y (2010) Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. PLoS ONE 5: e15543.